SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

OBJECTIVES: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) produced good tumor response in cases with lung squamous cell carcinoma, one of the most difficult cancers to treat. Secreted protein acidic and rich in cysteine (SPARC) binds to albumin, suggesting that SPARC plays an important role...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Onco Targets Ther
Glavni autori: Komiya, Kazutoshi, Nakamura, Tomomi, Nakashima, Chiho, Takahashi, Koichiro, Umeguchi, Hitomi, Watanabe, Naomi, Sato, Akemi, Takeda, Yuji, Kimura, Shinya, Sueoka-Aragane, Naoko
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2016
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5089830/
https://ncbi.nlm.nih.gov/pubmed/27822069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114492
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items